Literature DB >> 33637223

Cochlear implantation for patients with tinnitus - A systematic review.

Kelly K S Assouly1, Jan A A van Heteren2, Robert J Stokroos2, Inge Stegeman2, Adriana L Smit2.   

Abstract

BACKGROUND: Cochlear implantation (CI) is used in patients with severe-to-profound hearing loss when hearing aids provide limited or no benefit for speech perception. Studies on this topic reported tinnitus reduction as a common side effect of the electrical activation after cochlear implantation. So far, it is unclear what the effect is when patients do receive their implant primarily because of tinnitus complaints.
OBJECTIVES: To assess the effectiveness of the electrical stimulation with a cochlear implant in patients with tinnitus as a primary complaint, by systematically reviewing the literature.
METHODS: Two independent authors identified studies, extracted data and assessed risk of bias of included studies. Original studies reporting outcomes of electrical stimulation by cochlear implantation for primarily tinnitus (defined as severe or incapacitating distress levels) were included, if they reported a follow-up of at least three months. The pre- and post-implantation tinnitus distress scores on single and/or multi-item questionnaires of the included studies were extracted.
RESULTS: In total, 4091 unique articles were retrieved. After screening titles, abstracts and full texts, we included seven prospective cohort studies (105 subjects in total, range: 10-26). All studies had considerable risks of bias. All tinnitus patients in the included studies had asymmetrical hearing loss or single-sided deafness. A statistically significant tinnitus distress improvement based on tinnitus questionnaire scores was found in every study.
CONCLUSION: Our systematic review reveals that electrical stimulation by cochlear implants in patients with a primary complaint of tinnitus has a positive impact on tinnitus distress. Nevertheless, only small sample sizes were found and studies showed considerable risks of bias.a.
© 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asymmetrical hearing loss; Cochlear implant; Single-sided deafness; Systematic review; Tinnitus

Year:  2020        PMID: 33637223     DOI: 10.1016/bs.pbr.2020.06.013

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  5 in total

1.  Effect of electrical stimulation with a cochlear implant on tinnitus impact: protocol of an individual patient data meta-analysis.

Authors:  Kelly Assouly; Adriana L Smit; Inge Stegeman
Journal:  BMJ Open       Date:  2022-06-17       Impact factor: 3.006

2.  Cochlear Implant Evolving Indications: Our Outcomes in Adult Patients.

Authors:  Andrea Achena; Francesco Achena; Alberto Giulio Dragonetti; Serena Sechi; Andrea Walter Pili; Maria Cristina Locci; Giuseppe Turnu; Antonino Maniaci; Salvatore Ferlito
Journal:  Audiol Res       Date:  2022-08-07

3.  Influence of tinnitus annoyance on hearing-related quality of life in cochlear implant recipients.

Authors:  Kelly K S Assouly; Remo A G J Arts; Petra L Graham; Bas van Dijk; Chris J James
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

4.  Analysis of a Cochlear Implant Database: Changes in Tinnitus Prevalence and Distress After Cochlear Implantation.

Authors:  Kelly K S Assouly; Adriana L Smit; Robert H Eikelboom; Cathy Sucher; Marcus Atlas; Robert J Stokroos; Inge Stegeman
Journal:  Trends Hear       Date:  2022 Jan-Dec       Impact factor: 3.496

Review 5.  Multidisciplinary Tinnitus Research: Challenges and Future Directions From the Perspective of Early Stage Researchers.

Authors:  Jorge Piano Simoes; Elza Daoud; Maryam Shabbir; Sana Amanat; Kelly Assouly; Roshni Biswas; Chiara Casolani; Albi Dode; Falco Enzler; Laure Jacquemin; Mie Joergensen; Tori Kok; Nuwan Liyanage; Matheus Lourenco; Punitkumar Makani; Muntazir Mehdi; Anissa L Ramadhani; Constanze Riha; Jose Lopez Santacruz; Axel Schiller; Stefan Schoisswohl; Natalia Trpchevska; Eleni Genitsaridi
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.